Happy Health’s ring secures FDA clearance for blood pressure measurement
October 6, 2026
Happy Health’s Happy Ring previously secured FDA approval for its use in the diagnosis and monitoring of sleep apnoea.
Happy Health’s Happy Ring previously secured FDA approval for its use in the diagnosis and monitoring of sleep apnoea.
The Class II decision-support software analyses lung sound recordings from compatible FDA-cleared electronic stethoscopes and flags recordings suggestive of wheeze for clinical review.
SwiftSight Body Composition is designed around a scan of less than five minutes, followed by automated AI analysis
The newly granted patent protects intraluminal systems and instruments that operate from within a bodily lumen.
ABBOTT PARK, Ill., Oct. 5, 2026 /PRNewswire/ — Abbott (NYSE: ABT), the global healthcare leader, today announced U.S. Food and Drug Administration (FDA) approval for updates to the CardioMEMS HF System that enable new patient-facing capabilities through the CardioGuide HF App.
Wristband device from Encora Therapeutics started as a project in 2.009, MIT’s iconic product-design class.
MARLBOROUGH, Mass., Oct. 1, 2026 /PRNewswire/ — BTL Industries, a global leader in medical and wellness technologies, today announced expanded FDA clearances for EXOMIND®, its noninvasive brain stimulation platform.
Medtronic plans to study the device in patients with peripheral artery disease below the knee, a historically difficult condition to treat.
Edwards Lifesciences earned FDA approval for its Autus size-adjustable heart valve, a surgical pulmonary heart valve for pediatric patients with congenital heart disease, the company announced today.
Agency assigns zalunfiban (DisaggproTM) a PDUFA target action date of June 18, 2027